Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
2005 1
2007 1
2009 3
2010 2
2011 1
2013 4
2014 1
2015 1
2016 1
2017 2
2018 3
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Cited In for PMID: 6292615

20 results
Results by year
Filters applied: . Clear all
Page 1
Opioid agonist and antagonist bivalent ligands as receptor probes.
Portoghese PS, Ronsisvalle G, Larson DL, Yim CB, Sayre LM, Takemori AE. Portoghese PS, et al. Life Sci. 1982 Sep 20-27;31(12-13):1283-6. doi: 10.1016/0024-3205(82)90362-9. Life Sci. 1982. PMID: 6292615
Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors.
Lensing CJ, Freeman KT, Schnell SM, Speth RC, Zarth AT, Haskell-Luevano C. Lensing CJ, et al. J Med Chem. 2019 Jan 10;62(1):144-158. doi: 10.1021/acs.jmedchem.8b00238. Epub 2018 May 9. J Med Chem. 2019. PMID: 29669202 Free PMC article.
Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
Carli M, Kolachalam S, Aringhieri S, Rossi M, Giovannini L, Maggio R, Scarselli M. Carli M, et al. Curr Neuropharmacol. 2018 Jan 30;16(2):222-230. doi: 10.2174/1570159X15666170518151127. Curr Neuropharmacol. 2018. PMID: 28521704 Free PMC article. Review.
Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.
Ericson MD, Lensing CJ, Fleming KA, Schlasner KN, Doering SR, Haskell-Luevano C. Ericson MD, et al. Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt A):2414-2435. doi: 10.1016/j.bbadis.2017.03.020. Epub 2017 Mar 29. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 28363699 Free PMC article. Review.
A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage.
Lensing CJ, Adank DN, Wilber SL, Freeman KT, Schnell SM, Speth RC, Zarth AT, Haskell-Luevano C. Lensing CJ, et al. ACS Chem Neurosci. 2017 Jun 21;8(6):1262-1278. doi: 10.1021/acschemneuro.6b00399. Epub 2017 Feb 16. ACS Chem Neurosci. 2017. PMID: 28128928 Free PMC article.
PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor.
Dix AV, Conroy JL, George Rosenker KM, Sibley DR, Appella DH. Dix AV, et al. ACS Med Chem Lett. 2015 Mar 13;6(4):425-9. doi: 10.1021/ml500478m. eCollection 2015 Apr 9. ACS Med Chem Lett. 2015. PMID: 25893044 Free PMC article.
20 results
Jump to page
Feedback